EO 14398 BAA identification and performance assessment of medical devices in electronic health record data development of a transparent and repeatable framework to enhance medical device integration…
Active Definitive Contract Awarded Last action
- Contract number
- 75F40126C00065
- Awardee
-
Rutgers The State University Of New Jersey UEI YVVTQD8CJC79
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $6,515,098
Award facts
- Opportunity
-
- FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Special Notice · FDABAA2600123 · Posted Nov 21, 2025
- Contract value 19% obligated
-
- $6,515,098.00 Current, with exercised options
- $35,194,704.00 Potential, with all options
- Completion date 2% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Piscataway, NJ 08854, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $6,515,098 |
About this award
The Food and Drug Administration awarded a $35.19 million definitive contract to Rutgers The State University Of New Jersey (doing business as RBHS-School of Nursing) on September 15, 2026, for identification and performance assessment of medical devices in electronic health record data and development of a transparent and repeatable framework to enhance medical device integration in real-world evidence generation under Executive Order 14398.
The contract is firm fixed price with no set-aside applied. Place of performance is Piscataway, NJ. The originating solicitation is the FY26 FDA Broad Agency Announcement for Advanced Research and Development of Regulatory Science, posted November 21, 2025, with proposals due February 24, 2026. The announcement seeks basic and applied research supporting regulatory science across FDA-regulated domains, with priority areas including new approach methodologies, analytical and computational methods, biomarkers, clinical outcome assessments, and emerging technologies.
The contract runs through September 23, 2031. Work falls under NAICS 541714 (Research and Development in Biotechnology) and PSC code AJ11 (General Science and Technology R&D Services).
Description
EO 14398 BAA identification and performance assessment of medical devices in electronic health record data development of a transparent and repeatable framework to enhance medical device integration in real world evidence generation
Quick answers
Who was awarded contract 75F40126C00065?
75F40126C00065 was awarded to Rutgers The State University Of New Jersey by Food and Drug Administration (Department of Health and Human Services) on September 15, 2026.
How much is contract 75F40126C00065 worth?
The government has obligated $6,515,098 on 75F40126C00065. Its potential value, with all options, is $35,194,704.
Was contract 75F40126C00065 competed?
The extent of competition for 75F40126C00065 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award